Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

EBV infection causes mononucleosis and is associated with specific subsets of B cell lymphomas. Immunosuppressed patients such as organ transplant recipients are particularly susceptible to EBV-induced lymphoproliferative disease (LPD), which can be fatal. Leflunomide (a drug used to treat rheumatoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilger, Andrea, Plowshay, Julie, Ma, Shidong, Nawand ar, Dhananjay, Barlow, Elizabeth A., Romero-Masters, James C., Bristol, Jillian A., Li, Zhe, Tsai, Ming-Han, Delecluse, Henri-Jacques, Kenney, Shannon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546479/
https://www.ncbi.nlm.nih.gov/pubmed/28574826
http://dx.doi.org/10.18632/oncotarget.17863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546479/
https://www.ncbi.nlm.nih.gov/pubmed/28574826
http://dx.doi.org/10.18632/oncotarget.17863

Ejemplares similares